• Explore /
  • Poster
  • / Neoadjuvant SBRT plus regional nodal irradiation with concurrent capecitabine for patients with resectable pancreatic cancer: Survival analysis of prospective phase 1 trial.

Neoadjuvant SBRT plus regional nodal irradiation with concurrent capecitabine for patients with resectable pancreatic cancer: Survival analysis of prospective phase 1 trial.

Abstract Poster

Authors

Mustafa Basree

Mustafa Basree

Department of Human Oncology, University of Wisconsin–Madison, Madison, WI

Mustafa Basree , Jacob Witt , Sharon M. Weber , Nataliya Volodymyrivna Uboha , Rebecca Minter , Meghan G. Lubner , Daniel Erik Abbott , Dustin A. Deming , Noelle K. LoConte , Syed Nabeel Zafar , Monica Arun Patel , Sam Joseph Lubner , Jeremy D. Kratz , Mark A. Ritter , Pranshu Mohindra , Michael F. Bassetti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT1918644

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 652)

DOI

10.1200/JCO.2024.42.3_suppl.652

Abstract #

652

Poster Bd #

L1

Abstract Disclosures

Similar Posters

First Author: Cullen M. Taniguchi

First Author: Roxane Mari

First Author: Marsha Reyngold

First Author: Fang Liu